BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 8039976)

  • 1. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin.
    Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
    Int J Dermatol; 1994 May; 33(5):361-6. PubMed ID: 8039976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell tryptase and chymase in developing and mature psoriatic lesions.
    Harvima IT; Naukkarinen A; Paukkonen K; Harvima RJ; Aalto ML; Schwartz LB; Horsmanheimo M
    Arch Dermatol Res; 1993; 285(4):184-92. PubMed ID: 8342961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions.
    Naukkarinen A; Harvima I; Paukkonen K; Aalto ML; Horsmanheimo M
    Arch Dermatol Res; 1993; 285(6):341-6. PubMed ID: 7692828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
    Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M
    Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin.
    Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
    Arch Dermatol Res; 1990; 282(7):428-33. PubMed ID: 1706585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative histochemical analysis of mast cells and sensory nerves in psoriatic skin.
    Naukkarinen A; Järvikallio A; Lakkakorpi J; Harvima IT; Harvima RJ; Horsmanheimo M
    J Pathol; 1996 Oct; 180(2):200-5. PubMed ID: 8976881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus.
    Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
    Acta Derm Venereol; 1991; 71(5):394-8. PubMed ID: 1721758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cutaneous mast cells and sensory nerves with psychic stress in psoriasis.
    Harvima IT; Viinamäki H; Naukkarinen A; Paukkonen K; Neittaanmäki H; Harvima RJ; Horsmanheimo M
    Psychother Psychosom; 1993; 60(3-4):168-76. PubMed ID: 8272475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase.
    Caughey GH; Leidig F; Viro NF; Nadel JA
    J Pharmacol Exp Ther; 1988 Jan; 244(1):133-7. PubMed ID: 2447273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors.
    Kaminska R; Naukkarinen A; Glinski W; Horsmanheimo M; Harvima IT
    Acta Derm Venereol; 1999 Sep; 79(5):351-5. PubMed ID: 10494709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
    Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
    J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
    Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema.
    Järvikallio A; Harvima IT; Naukkarinen A
    Arch Dermatol Res; 2003 Apr; 295(1):2-7. PubMed ID: 12709813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
    Kivinen PK; Kaminska R; Naukkarinen A; Harvima RJ; Horsmanheimo M; Harvima IT
    Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of tryptase- and chymase-containing mast cells in atopic dermatitis and nummular eczema.
    Järvikallio A; Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M
    Br J Dermatol; 1997 Jun; 136(6):871-7. PubMed ID: 9217819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural examination of tryptase- and chymase-positive mast cells in livers, containing metastases from gastrointestinal cancers.
    Gulubova MV
    Clin Exp Metastasis; 2003; 20(7):611-20. PubMed ID: 14669792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of tryptase and chymase containing mast cells in benign and malignant breast lesions.
    Kankkunen JP; Harvima IT; Naukkarinen A
    Int J Cancer; 1997 Jul; 72(3):385-8. PubMed ID: 9247277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M; Harvima IT
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis.
    Chan J; Smoller BR; Raychauduri SP; Jiang WY; Farber EM
    Arch Dermatol Res; 1997 Oct; 289(11):611-6. PubMed ID: 9444383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis.
    Badertscher K; Brönnimann M; Karlen S; Braathen LR; Yawalkar N
    Arch Dermatol Res; 2005 Apr; 296(10):503-6. PubMed ID: 15703960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.